Studies indicate TOMM40 variants are associated with estimating onset of Alzheimer disease and interaction with ApoE status can increase disease onset, which may be geographically dependent.120 We found that TOMM40 expression was significantly increased in Braak stage III compared to I/II with no difference in transcript variants based on reference-guided assembly. This evidence concerns the gene APOE and Alzheimer disease.